Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Plasma Cell Disorders Multiple Myeloma Relapsed/Refractory 1-5 prior lines
Categories
Protocols
BEIGENE-BGB-11417-105 Phase I/II OPEN TO ACCRUAL
A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination with Dexamethasone and Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and t(11;14)